138 related articles for article (PubMed ID: 27663460)
1. Adherence to National Comprehensive Cancer Network® Guidelines for Testicular Cancer.
Wymer KM; Pearce SM; Harris KT; Pierorazio PM; Daneshmand S; Eggener SE
J Urol; 2017 Mar; 197(3 Pt 1):684-689. PubMed ID: 27663460
[TBL] [Abstract][Full Text] [Related]
2. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis.
Stokes W; Amini A; Maroni PD; Kessler ER; Stokes C; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
J Pediatr Urol; 2017 Aug; 13(4):386.e1-386.e7. PubMed ID: 28153774
[TBL] [Abstract][Full Text] [Related]
3. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
Pfaendler KS; Chang J; Ziogas A; Bristow RE; Penner KR
Obstet Gynecol; 2018 May; 131(5):899-908. PubMed ID: 29630020
[TBL] [Abstract][Full Text] [Related]
4. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
[TBL] [Abstract][Full Text] [Related]
5. Impact of Non-guideline-directed Care on Quality of Life in Testicular Cancer Survivors.
Saoud RM; Andolfi C; Aizen J; Wymer K; Burg M; Barashi N; Daneshmand S; Eggener S
Eur Urol Focus; 2021 Sep; 7(5):1137-1142. PubMed ID: 33121935
[TBL] [Abstract][Full Text] [Related]
6. Retroperitoneal lymph node dissection for testicular seminomas: population-based practice and survival outcomes.
Patel HD; Joice GA; Schwen ZR; Semerjian A; Alam R; Srivastava A; Allaf ME; Pierorazio PM
World J Urol; 2018 Jan; 36(1):73-78. PubMed ID: 29026972
[TBL] [Abstract][Full Text] [Related]
7. Survival After Early-Stage Breast Cancer of Women Previously Treated for Depression: A Nationwide Danish Cohort Study.
Suppli NP; Johansen C; Kessing LV; Toender A; Kroman N; Ewertz M; Dalton SO
J Clin Oncol; 2017 Jan; 35(3):334-342. PubMed ID: 28095267
[TBL] [Abstract][Full Text] [Related]
8. Testicular cancer guideline adherence and patterns of care in Germany: A nationwide survey.
Nestler T; Baunacke M; Dräger D; von Landenberg N; Groeben C; Huber J
Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12917. PubMed ID: 30252174
[TBL] [Abstract][Full Text] [Related]
9. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
[TBL] [Abstract][Full Text] [Related]
10. Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
Bristow RE; Chang J; Ziogas A; Anton-Culver H
Obstet Gynecol; 2013 Jun; 121(6):1226-1234. PubMed ID: 23812456
[TBL] [Abstract][Full Text] [Related]
11. The management of testicular cancer in Victoria, 1988-1993. Urology Study Committee of the Victorian Co-operative Oncology Group.
Toner GC; Neerhut GJ; Schwarz MA; Thursfield VJ; Sandeman TF; Giles GG; Snow RM
Med J Aust; 2001 Apr; 174(7):328-31. PubMed ID: 11346104
[TBL] [Abstract][Full Text] [Related]
12. The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985-1996.
Steele GS; Richie JP; Stewart AK; Menck HR
Cancer; 1999 Nov; 86(10):2171-83. PubMed ID: 10570449
[TBL] [Abstract][Full Text] [Related]
13. Adherence with operative standards in the treatment of gastric cancer in the United States.
Zhao B; Blair SL; Katz MHG; Lowy AM; Kelly KJ
Gastric Cancer; 2020 May; 23(3):550-560. PubMed ID: 31745679
[TBL] [Abstract][Full Text] [Related]
14. Management trends in stage I testicular seminoma: Impact of race, insurance status, and treatment facility.
Gray PJ; Lin CC; Sineshaw H; Paly JJ; Jemal A; Efstathiou JA
Cancer; 2015 Mar; 121(5):681-7. PubMed ID: 25345675
[TBL] [Abstract][Full Text] [Related]
15. Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry.
Yap SA; Yuh LM; Evans CP; Dall'Era MA; Wagenaar RM; Cress R; Lara PN
World J Urol; 2017 Feb; 35(2):277-283. PubMed ID: 27306686
[TBL] [Abstract][Full Text] [Related]
16. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
[TBL] [Abstract][Full Text] [Related]
17. National survey of patterns of care for testis cancer.
Kennedy BJ; Schmidt JD; Winchester DP; Peace BL; Natarajan N; Mettlin C
Cancer; 1987 Oct; 60(8):1921-30. PubMed ID: 3652018
[TBL] [Abstract][Full Text] [Related]
18. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.
Fosså SD; Chen J; Schonfeld SJ; McGlynn KA; McMaster ML; Gail MH; Travis LB
J Natl Cancer Inst; 2005 Jul; 97(14):1056-66. PubMed ID: 16030303
[TBL] [Abstract][Full Text] [Related]
19. Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Gilligan T; Lin DW; Aggarwal R; Chism D; Cost N; Derweesh IH; Emamekhoo H; Feldman DR; Geynisman DM; Hancock SL; LaGrange C; Levine EG; Longo T; Lowrance W; McGregor B; Monk P; Picus J; Pierorazio P; Rais-Bahrami S; Saylor P; Sircar K; Smith DC; Tzou K; Vaena D; Vaughn D; Yamoah K; Yamzon J; Johnson-Chilla A; Keller J; Pluchino LA
J Natl Compr Canc Netw; 2019 Dec; 17(12):1529-1554. PubMed ID: 31805523
[TBL] [Abstract][Full Text] [Related]
20. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]